Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease

Amyloid chronicity predicts a 14-year preclinical AD phase in ADAD. SILA accurately estimates age at A+ (MAE < 2 years). EYO outperforms chronicity in predicting symptom onset. APP mutation carriers show atypical amyloid accumulation. Chronicity models help reveal AD heterogeneity in preclinical stages.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-10-01
DOI
https://doi.org/10.1002/alz.70812
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease

Tammie L.S. Benzinger, Nicole S. McKay, Jee Hoon Roh, Mathias Jucker et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease

Tammie L.S. Benzinger, Nicole S. McKay, Jee Hoon Roh, Mathias Jucker, Tobey J. Betthauser, Randall John Bateman, Christopher R S Belder, David Fernando Aguillon, Carlos Cruchaga, Peter R Millar, David M. Cash, Stephanie A. Schultz, Matthew Zammit, Julie K. Wisch, Patricio Chrem, Gregory Scott Day, Eric McDade, Guoqiao Wang, Igor Yakushev, Laura Ibáñez, Beau M. Ances, Yan Li, Natalie S. Ryan, Mike Murphy, Brian A. Gordon, Jorge J. Llibre‐Guerra, Bradley T. Christian, Cliff R Jack, Suzanne E. Schindler, Chengjie Xiong
article en

Abstract

Amyloid chronicity predicts a 14-year preclinical AD phase in ADAD. SILA accurately estimates age at A+ (MAE < 2 years). EYO outperforms chronicity in predicting symptom onset. APP mutation carriers show atypical amyloid accumulation. Chronicity models help reveal AD heterogeneity in preclinical stages.

Alzheimer s & DementiaVol. 21(10)
Royal Adelaide Hospital (AU), Mayo Clinic (US), University of Wisconsin–Madison (US), Morpho (United States) (US), Washington University in St. Louis (US), German Center for Neurodegenerative Diseases (DE), Jacksonville College (US), TUM Klinikum (DE), Universidad de Antioquia (CO), Massachusetts General Hospital (US), Queen Elizabeth Hospital (AU), Hope Center for Neurological Disorders (US), Mayo Clinic in Arizona (US), UK Dementia Research Institute (GB), Hertie Institute for Clinical Brain Research (DE), Mayo Clinic in Florida (US), National Hospital for Neurology and Neurosurgery (GB), Korea University (JP), University College London (GB), The University of Adelaide (AU), University of Tübingen (DE)
Alzheimer's Association, Foundation for Barnes-Jewish Hospital, Japan Agency for Medical Research and Development, Hope Center for Neurological Disorders, University College London, Deutsches Zentrum für Neurodegenerative Erkrankungen, Ministry of Science and ICT, South Korea, Fleni, Instituto de Salud Carlos III, National Institute on Aging
Openalex Percentile: Top 63%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.